Advancements in antibody technologies and protein data are driving new possibilities in cancer research, enabling the identification of novel biomarkers and enhancing therapeutic strategies. In this ...
Mission Statement: Evidence-based Complementary and Alternative Medicine (eCAM) is an international, peer-reviewed journal that seeks to understand the sources and to encourage rigorous research ...
To describe a case of Progressive Encephalopathy with or without Lipodystrophy (PELD), characterized by a late onset of neurological regression at 9 years old, due to a homozygous c.974dupG variant in ...
Septerna Inc. has announced its decision to discontinue a healthy volunteer phase I trial of SEP-786, an oral small-molecule agonist of the parathyroid hormone 1 receptor being developed for the ...
Savefor later Page saved! You can go back to this later in your Diabetes and Me Close ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results